Mallinckrodt PLC (NYSE:MNK)’s share price rose 5.6% during trading on Friday . The company traded as high as $9.73 and last traded at $9.61. Approximately 3,566,030 shares traded hands during mid-day trading, an increase of 61% from the average daily volume of 2,209,127 shares. The stock had previously closed at $9.10.

Several equities analysts have commented on MNK shares. ValuEngine downgraded Mallinckrodt from a “hold” rating to a “sell” rating in a report on Tuesday, March 5th. Morgan Stanley set a $32.00 price target on Mallinckrodt and gave the company a “hold” rating in a report on Thursday, February 28th. Mizuho lowered their price target on Mallinckrodt from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Thursday, May 16th. SunTrust Banks started coverage on Mallinckrodt in a report on Tuesday, March 19th. They set a “hold” rating and a $23.00 price target on the stock. Finally, Canaccord Genuity set a $40.00 price target on Mallinckrodt and gave the company a “buy” rating in a report on Monday, March 18th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $26.72.

The company has a market capitalization of $827.24 million, a PE ratio of 1.20, a price-to-earnings-growth ratio of 0.10 and a beta of 2.12. The company has a current ratio of 1.45, a quick ratio of 1.08 and a debt-to-equity ratio of 1.90.

Mallinckrodt (NYSE:MNK) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.21. The business had revenue of $791.00 million for the quarter, compared to the consensus estimate of $766.27 million. Mallinckrodt had a negative net margin of 118.53% and a positive return on equity of 14.22%. Mallinckrodt’s quarterly revenue was up 4.7% on a year-over-year basis. During the same quarter last year, the company posted $1.31 earnings per share. Equities research analysts forecast that Mallinckrodt PLC will post 8.38 earnings per share for the current fiscal year.

Several institutional investors have recently made changes to their positions in the company. QS Investors LLC grew its stake in shares of Mallinckrodt by 14.3% in the fourth quarter. QS Investors LLC now owns 4,000 shares of the company’s stock worth $64,000 after acquiring an additional 500 shares during the last quarter. Sheaff Brock Investment Advisors LLC grew its stake in shares of Mallinckrodt by 4.6% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 13,440 shares of the company’s stock worth $212,000 after acquiring an additional 594 shares during the last quarter. Martingale Asset Management L P grew its stake in shares of Mallinckrodt by 0.8% in the fourth quarter. Martingale Asset Management L P now owns 76,053 shares of the company’s stock worth $1,202,000 after acquiring an additional 597 shares during the last quarter. Retirement Systems of Alabama grew its stake in shares of Mallinckrodt by 0.6% in the first quarter. Retirement Systems of Alabama now owns 108,703 shares of the company’s stock worth $2,363,000 after acquiring an additional 685 shares during the last quarter. Finally, Arizona State Retirement System grew its stake in shares of Mallinckrodt by 1.2% in the fourth quarter. Arizona State Retirement System now owns 59,797 shares of the company’s stock worth $945,000 after acquiring an additional 714 shares during the last quarter.

ILLEGAL ACTIVITY WARNING: “Mallinckrodt (MNK) Stock Price Up 5.6%” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://theolympiareport.com/2019/05/24/mallinckrodt-mnk-stock-price-up-5-6.html.

Mallinckrodt Company Profile (NYSE:MNK)

Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.

Further Reading: Why do companies issue stock splits?

Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.